AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ETHAMBUTOL
9 registrations across 5 African markets— 6 active
Markets with ETHAMBUTOL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| RIFAFOUR e-275 | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Jan 2024 |
| ETHAMBUTOL 400MG TABLET TABLET/20X10 | 🇳🇬Nigeria | NEROS PHARM. LIMITED. 1 | expired | Mar 2022 |
| MYRIN-P FORTE | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Nov 2021 |
| KOXIRIP TABLETS | 🇿🇦South Africa | Innovata Pharmaceuticals | active | Jan 1900 |
| RIMSTAR 4-FDC | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| Ethambutol Dispersible Tablets 100 mg Dispersible Tablets | 🇹🇿Tanzania | lupin limited | active | — |
| ETHAMBUTOL MACLEODS comprimé / 400 mg | 🇸🇳Senegal | MACLEODS PHARMACEUTICALS LTD | active | — |
| ETHAMBUTOL MACLEODS comprimé / 400 mg | 🇸🇳Senegal | NESTOR PHARMACEUTICALS LIMITED | active | — |
| ETHAMBUTOL PHARMA COMPRIME | 🇲🇦Morocco | — | active | — |
ETHAMBUTOL in Africa — Regulatory Overview
ETHAMBUTOL is registered across 5 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Senegal, Morocco, Nigeria and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.